Shopping Cart
- Remove All
- Your shopping cart is currently empty
BAY 73-6691 racemate (Rac-BAY 73-6691) is a phosphodiesterase 9A (PDE9A) inhibitor used for research in Parkinson's disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $258 | 7-10 days | |
1 mL x 10 mM (in DMSO) | $278 | 7-10 days |
Description | BAY 73-6691 racemate (Rac-BAY 73-6691) is a phosphodiesterase 9A (PDE9A) inhibitor used for research in Parkinson's disease. |
In vitro | The BAY 73-6691 racemate is the BAY 73-6691 racemate. Treatment with BAY 73-6691 (50, 100, 150, and 200μg/mL) attenuated the cytotoxicity and oxidative stress of Aβ25-35-induced SH-SY5Y cells. [3] |
In vivo | BAY 73-6691 (1 mg/kg/ day and 5 mg/kg/ day) for 95 days. The 5/6Nx rats developed albuminuria, decreased serum creatinine clearance (Ccr), and increased serum troponin T levels. [2] In A mouse model, BAY 73-6691 (intraperitoneal injection) protected hippocampal neurons from oxidative damage induced by Aβ25-35. [3] |
Alias | Rac-BAY 73-6691, BAY 736691 racemate |
Molecular Weight | 356.73 |
Formula | C15H12ClF3N4O |
Cas No. | 794568-90-4 |
Smiles | O=C1N=C(NC2=C1C=NN2C=3C=CC=CC3Cl)CC(C)C(F)(F)F |
Relative Density. | 1.52 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (224.26 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.